Bupivicaine to Reduce Postoperative Pain in Laparoscopic Ventral Hernia Repair
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01530815 |
Recruitment Status : Unknown
Verified February 2012 by Chang, Steve S., M.D..
Recruitment status was: Recruiting
First Posted : February 10, 2012
Last Update Posted : February 10, 2012
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Postoperative Pain | Drug: Bupivicaine Infusion | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 80 participants |
Allocation: | N/A |
Intervention Model: | Single Group Assignment |
Masking: | Triple (Participant, Care Provider, Investigator) |
Primary Purpose: | Treatment |
Official Title: | Intraoperative Local Anesthesia for Management of Postoperative Pain Following Laparoscopic Ventral Hernia Repair: a Prospective Double-blind Randomized Trial |
Study Start Date : | August 2011 |
Estimated Primary Completion Date : | January 2013 |
Estimated Study Completion Date : | January 2013 |
Arm | Intervention/treatment |
---|---|
Experimental: Bupivicaine Infusion
We will infuse bupivicaine between the abdominal wall and mesh to try and reduce postoperative pain
|
Drug: Bupivicaine Infusion
Investigators and Caregivers will be blinded to either 0.9% Normal Saline or 0.5% Bupivicaine infusion between the mesh and abdominal wall
Other Name: Marcaine |
- Pain [ Time Frame: 24 hours ]We will measure pain based on pain journal and usage of postoperative pain medication

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Patient must be scheduled for a laparoscopic ventral hernia repair at SBCH. If any additional procedure is performed, the subject will be excluded from the study
- Age 18 or older
- Patient must agree to complete pain journal postoperatively
- Informed consent signed and dated by patient. Consenting through a legally authorized guardian will not be accepted due to the necessity of completing a subjective pain journal
Exclusion Criteria:
- Any surgical procedure occurring besides the study procedure
- Any allergy or sensitivity to bupivicaine or its derivatives
- Less than 18 years of age
- Patient unable to self report in pain journal due to cognitive disabilities
- Discharged less than 4 hours post-surgery

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01530815
Contact: Steve Chang, MD | 805-637-0217 | s1chang@sbch.org |
United States, California | |
Santa Barbara Cottage Hospital | Recruiting |
Santa Barbara, California, United States, 93105 | |
Contact: Steve S Chang, MD 805-637-0217 s1chang@sbch.org |
Principal Investigator: | Steve S Chang, MD | Santa Barbara Cottage Hospital |
Responsible Party: | Chang, Steve S., M.D. |
ClinicalTrials.gov Identifier: | NCT01530815 |
Other Study ID Numbers: |
LapHernia_SBCH |
First Posted: | February 10, 2012 Key Record Dates |
Last Update Posted: | February 10, 2012 |
Last Verified: | February 2012 |
Pain, Postoperative Hernia, Ventral Postoperative Complications Pathologic Processes Pain Neurologic Manifestations Hernia Pathological Conditions, Anatomical |
Hernia, Abdominal Bupivacaine Anesthetics, Local Anesthetics Central Nervous System Depressants Physiological Effects of Drugs Sensory System Agents Peripheral Nervous System Agents |